Skip To Main Content
Eralda Mema on Muck Rack

Eralda Mema

As seen in: Clinical Imaging
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eralda

Contact Eralda, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Axillary lymphadenopathy following bivalent COVID-19 booster vaccination

|
By Elizabeth Lane, Kemi Babagbemi, Eralda Mema, Katerina Dodelzon
| Clinical Imaging Verified
]. The Moderna bivalent booster contains 25 μg of the nucleoside-modified mRNA that was used in the original vaccine that encodes the “prefusion stabilized Spike glycoprotein (S) of the SARS-CoV-2 Wuhan-Hu-1 strain” and 25 μg of mRNA that encodes “the pre-fusion stabilized S-protein of the SARS-CoV-2 Omicron variant lineages BA.4 and BA.5”. [ 2. Moderna HCP FS for bivalent booster for 6 years and older (Gray Label) 10122022. The U.S. Food and Drug Administration.
Open in Who Shared Issue with article?
See all 1 articles